REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Embiotic Laboratories Private Limited (India)

Main Activities: Forestry and Logging
Full name: Embiotic Laboratories Private Limited Profile Updated: March 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Embiotic Laboratories is a pharmaceutical company that focuses on R&D, formulation optimization, process development, and stability studies, aiming to increase market share and become a leading pharmaceutical organization in India.

Legal Address
20C Kumbalgodu Indl. Area, 1St Phase, Kumbalgodu Mysore Road,
Bangalore; Karnataka; Postal Code: 560074

Contact Details: Purchase the Embiotic Laboratories Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Embiotic Laboratories Private Limited report to view the information.
Registered Capital:
Purchase the Embiotic Laboratories Private Limited report to view the information.
Financial Auditors:
Purchase the Embiotic Laboratories Private Limited report to view the information.
Incorporation Date:
August 29, 1988
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
24.86%
Purchase this report to view the information.
8.66%
Company Performance
Financial values in the chart are available after Embiotic Laboratories Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
3.59%▲
Total operating revenue
3.49%▲
Operating Profit/Loss (EBIT)
30.73%▲
EBITDA
15.19%▲
Net Profit/Loss for the Period
551.31%▲
Total Assets
6.12%▲
Total Equity
2.61%▲
Operating Profit Margin (ROS)
1.37%▲
Net Profit Margin
1.18%▲
Return on Equity (ROE)
8.05%▲
Debt/Equity
70.84%▲
Quick Ratio
0.95%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo